Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC)

被引：0
|
作者：
McKay, Rana R.
Kroeger, Nils
Xie, Wanling
Lee, Jae-Lyun
Knox, Jennifer J.
Bjarnason, Georg A.
MacKenzie, Mary J.
Wood, Lori
Srinivas, Sandy
Vaishampayan, Ulka N.
Rha, Sun Young
Pal, Sumanta Kumar
Donskov, Frede
Tantravahi, Srinivas
Rini, Brian I.
Heng, Daniel Yick Chin
Choueiri, Toni K.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Tom Baker Canc Clin, Calgary, AB, Canada
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[5] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[6] London Reg Canc Program, London, ON, Canada
[7] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[8] Stanford Med Ctr, Stanford, CA USA
[9] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[10] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
[11] City Hope Natl Med Ctr, Duarte, CA USA
[12] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[13] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[14] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[15] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol,Sch Med, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
394
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characteristics of metastatic renal cell carcinoma (mRCC) patients treated with delayed targeted therapy: Results from the International mRCC Consortium (IMDC).
    Li, Haoran
    Choueiri, Toni K.
    Wells, Connor
    Agarwal, Neeraj
    Donskov, Frede
    Lee, Jae-Lyun
    Broom, Reuben James
    Yuasa, Takeshi
    Rini, Brian I.
    Pal, Sumanta Kumar
    Wood, Lori
    Ernst, D. Scott
    Kollmannsberger, Christian K.
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Bjarnason, Georg A.
    Knox, Jennifer J.
    Saleem, Sadia
    Beuselinck, Benoit
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Prognostic significance of bone metastases (BM) and bisphosphonate (BIS) therapy in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs)
    Mckay, Rana R.
    Lin, Xun
    Perkins, Julia Jane
    Simantov, Ronit
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Stukalin, Igor
    Wells, Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Porta, Camillo
    Moreira, Raphael Brandao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [4] Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)
    Stukalina, Igor
    Wellsa, J. Connor
    Donskovb, Frede
    Rinic, Brian I.
    Leed, Jae-Lyun
    Bjarnasone, Georg A.
    Beuselinckf, Benoit
    Smoragiewicz, Martin
    Alvah, Ajjai Shivaram
    Srinivasi, Sandy
    Woodi, Lori
    Saleemk, Sadia
    Pal, Sumanta Kumar
    Yuasam, Takeshi
    Broomn, Reuben James
    Kanesvaran, Ravindran
    Bamiasp, Aristotelis
    Knoxq, Jennifer J.
    Henga, Daniel Y. C.
    Choueirir, Toni K.
    [J]. BJU INTERNATIONAL, 2015, 116 : 21 - 21
  • [5] Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Dudani, Shaan
    de Velasco, Guillermo
    Wells, Connor
    Gan, Chun Loo
    Donskov, Frede
    Porta, Camillo
    Fraccon, Anna
    Pasini, Felice
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Pal, Sumanta K.
    Hotte, Sebastien J.
    Lalani, Aly-Khan A.
    Yuasa, Takeshi
    Kanesvaran, Ravindran
    Reaume, M. Neil
    Canil, Christina M.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Stukalin, Igor
    Wells, J. Connor
    Fraccon, Anna
    Pasini, Felice
    Porta, Camillo
    Lalani, Aly-Khan A.
    Srinivas, Sandy
    Bowman, I. Alex
    Brugarolas, James
    Lee, Jae-Lyun
    Donskov, Frede
    Beuselinck, Benoit
    Bamias, Aristotelis
    Rini, Brian, I
    Sim, Hao-Wen
    Agarwal, Neeraj
    Rha, Sun-Young
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. KIDNEY CANCER, 2018, 2 (01) : 31 - 36
  • [8] Sites of metastasis and survival in metastatic renal-cell carcinoma (mRCC): Resuits from the international mRCC Database Consortium (IMDC)
    Dudani, Shaan
    de Velasco, Guillermo
    Wells, J. Connor
    Gan, Chun Loo
    Donskov, Frede
    Porta, Camillo
    Fraccon, Anna
    Pasini, Felice
    Hansen, Aaron
    Bjarnason, Georg
    Beuselinck, Benoit
    Pal, Sumanta K.
    Hotte, Sebastien
    Lalani, Aly-Khan A.
    Yuasa, Takeshi
    Kanesvaran, Ravindran
    Reaume, M. Neil
    Canil, Christina
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 4 - 4
  • [9] Impact of bone metastases (BM) and bisphosphonate use in patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy: Results from a pooled clinical trials database
    Mckay, R. R.
    Lin, X.
    Perkins, J. J.
    Heng, D. Y. C.
    Simantov, R.
    Choueiri, T. K.
    [J]. BJU INTERNATIONAL, 2013, 112 : 10 - 11
  • [10] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345